Similar articles for PMID: 27523973

Year	Number of Results
1997	1
1999	1
2005	1
2007	2
2008	2
2009	1
2010	1
2011	2
2012	8
2013	10
2014	8
2015	21
2016	26
2017	16
2018	21
2019	23
2020	13
2021	30
2022	17
2023	3
2024	0

1

Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.

Kuo FC. Kuo FC. Surg Pathol Clin. 2016 Sep;9(3):475-88. doi: 10.1016/j.path.2016.04.010. Surg Pathol Clin. 2016. PMID: 27523973 Review.

2

Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.

Kanagal-Shamanna R, Singh RR, Routbort MJ, Patel KP, Medeiros LJ, Luthra R. Kanagal-Shamanna R, et al. Expert Rev Mol Diagn. 2016;16(4):461-72. doi: 10.1586/14737159.2016.1142374. Epub 2016 Feb 15. Expert Rev Mol Diagn. 2016. PMID: 26765348 Review.

3

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.

Au CH, Wa A, Ho DN, Chan TL, Ma ES. Au CH, et al. Diagn Pathol. 2016 Jan 22;11:11. doi: 10.1186/s13000-016-0456-8. Diagn Pathol. 2016. PMID: 26796102 Free PMC article.

4

Next-generation sequencing-based panel testing for myeloid neoplasms.

Kuo FC, Dong F. Kuo FC, et al. Curr Hematol Malig Rep. 2015 Jun;10(2):104-11. doi: 10.1007/s11899-015-0256-3. Curr Hematol Malig Rep. 2015. PMID: 25933675 Review.

5

Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.

Shumilov E, Flach J, Pabst T, Fiedler M, Angelillo-Scherrer A, Trümper L, Joncourt R, Kohlmann A, Bacher U. Shumilov E, et al. Crit Rev Oncol Hematol. 2018 Jun;126:64-79. doi: 10.1016/j.critrevonc.2018.03.020. Epub 2018 Mar 29. Crit Rev Oncol Hematol. 2018. PMID: 29759569 Review.

6

Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.

Kohlmann A, Bacher U, Schnittger S, Haferlach T. Kohlmann A, et al. Leuk Lymphoma. 2014 Aug;55(8):1725-34. doi: 10.3109/10428194.2013.856427. Epub 2014 Feb 14. Leuk Lymphoma. 2014. PMID: 24144312 Review.

7

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.

Wang BH, Li YH, Yu L. Wang BH, et al. Chin Med J (Engl). 2015 Sep 5;128(17):2395-403. doi: 10.4103/0366-6999.163400. Chin Med J (Engl). 2015. PMID: 26315090 Free PMC article. Review.

8

Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.

Bartels S, Schipper E, Hasemeier B, Kreipe H, Lehmann U. Bartels S, et al. Oncotarget. 2016 May 24;7(21):30084-93. doi: 10.18632/oncotarget.8310. Oncotarget. 2016. PMID: 27029036 Free PMC article. Review.

9

Applications of next-generation sequencing in hematologic malignancies.

Ramkissoon LA, Montgomery ND. Ramkissoon LA, et al. Hum Immunol. 2021 Nov;82(11):859-870. doi: 10.1016/j.humimm.2021.02.006. Epub 2021 Feb 27. Hum Immunol. 2021. PMID: 33648805 Review.

10

Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.

Maes B, Willemse J, Broekmans A, Smets R, Cruys B, Put N, Madoe V, Janssen M, Soepenberg O, Bries G, Vrelust I, Achten R, Van Pelt K, Buvé K, Theunissen K, Peeters V, Froyen G. Maes B, et al. Int J Lab Hematol. 2017 Dec;39(6):604-612. doi: 10.1111/ijlh.12709. Epub 2017 Jul 19. Int J Lab Hematol. 2017. PMID: 28722833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

181 results

Results by year